Neurocrine Biosciences | 유동 부채

Current Liabilities 변화 날짜
AbbVie USD 34.77B 2.53B 2023-09
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Agios Pharmaceuticals USD 67.96M 9.53M 2023-12
ALKERMES USD 503.11M 15.92M 2023-09
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Amgen USD 18.39B 1.44B 2023-12
Cytokinetics USD 102.68M 24.96M 2023-12
Dynavax Technologies USD 62.2M 7.93M 2023-12
Exelixis USD 376.82M 37.2M 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Incyte USD 1.24B 115.7M 2023-12
Intra Cellular Therapies USD 123.54M 20.45M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Repligen USD 363.36M 10.22M 2023-09
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Teva Pharmaceutical Industries USD 11.39B 449M 2023-09
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09



Neurocrine Biosciences 유동 부채 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.